LIQUIDIA CORP (LQDA) — insider trading
Health Care · NASDAQ
LIQUIDIA CORP (LQDA) has 228 reported SEC Form 4 insider transactions in our data, including 45 open-market sales among the most recent 100 (latest 2026-10-05).
Recent Form 4 transactions
Showing the 100 most recent of 228 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bloch Stephen M | Director | Open-market sale | 235,477 | $27.13 | $6.39M | Form 4 |
| 2026-09-14 | SINGH RAMAN | Director | Option exercise / conversion (derivative) | 8,468 | — | $0 | Form 4 |
| 2026-09-14 | SINGH RAMAN | Director | Open-market sale | 8,468 | $66.16 | $560.2K | Form 4 |
| 2026-09-14 | SINGH RAMAN | Director | Option exercise / conversion | 8,468 | $9.31 | $78.8K | Form 4 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise / conversion (derivative) | 8,468 | — | $0 | Form 4 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise / conversion (derivative) | 556 | — | $0 | Form 4 |
| 2026-09-11 | SINGH RAMAN | Director | Open-market sale | 9,024 | $68.62 | $619.2K | Form 4 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise / conversion | 8,468 | $9.31 | $78.8K | Form 4 |
| 2026-09-11 | SINGH RAMAN | Director | Option exercise / conversion | 556 | $8.63 | $4.8K | Form 4 |
| 2026-09-01 | Krepp Sarah | Officer (Chief Human Resource Officer) | Open-market sale | 274 | $67.76 | $18.6K | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 238 | — | $0 | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 10,762 | — | $0 | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 11,799 | — | $0 | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 9,000 | — | $0 | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Open-market sale | 41,832 | $69.09 | $2.89M | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Open-market sale | 31,799 | $69.09 | $2.20M | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 238 | $14.20 | $3.4K | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 10,762 | $14.20 | $152.8K | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 11,799 | $9.31 | $109.8K | Form 4 |
| 2026-08-21 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 9,000 | $9.31 | $83.8K | Form 4 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise / conversion (derivative) | 6,666 | — | $0 | Form 4 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise / conversion (derivative) | 11,727 | — | $0 | Form 4 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Open-market sale | 18,393 | $72.23 | $1.33M | Form 4 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise / conversion | 6,666 | $2.59 | $17.3K | Form 4 |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Option exercise / conversion | 11,727 | $2.51 | $29.4K | Form 4 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise / conversion (derivative) | 13,334 | — | $0 | Form 4 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise / conversion (derivative) | 23,455 | — | $0 | Form 4 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Open-market sale | 36,789 | $74.99 | $2.76M | Form 4 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise / conversion | 13,334 | $2.59 | $34.5K | Form 4 |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Option exercise / conversion | 23,455 | $2.51 | $58.9K | Form 4 |
| 2026-08-19 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-08-19 | Saggar Rajeev | Officer (Chief Medical Officer) | Open-market sale | 50,000 | $74.06 | $3.70M | Form 4 |
| 2026-08-19 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion | 50,000 | $3.73 | $186.5K | Form 4 |
| 2026-08-17 | Saggar Rajeev | Officer (Chief Medical Officer) | Open-market sale | 29,534 | $76.84 | $2.27M | Form 4 |
| 2026-07-27 | Adair Jason | Officer (Chief Business Officer) | Open-market sale | 688 | $87.53 | $60.2K | Form 4 |
| 2026-07-27 | Boyle Dana | Officer (Chief Accounting Officer) | Open-market sale | 1,600 | $87.53 | $140.0K | Form 4 |
| 2026-07-23 | Bloch Stephen M | Director | Open-market sale | 3,600 | $90.71 | $326.5K | Form 4 |
| 2026-07-23 | Bloch Stephen M | Director | Open-market sale | 96,400 | $89.44 | $8.62M | Form 4 |
| 2026-07-22 | Bloch Stephen M | Director | Open-market sale | 14,562 | $89.24 | $1.30M | Form 4 |
| 2026-07-22 | Bloch Stephen M | Director | Open-market sale | 48,032 | $88.65 | $4.26M | Form 4 |
| 2026-07-22 | Bloch Stephen M | Director | Open-market sale | 37,406 | $87.70 | $3.28M | Form 4 |
| 2026-07-21 | Bloch Stephen M | Director | Open-market sale | 556 | $80.66 | $44.8K | Form 4 |
| 2026-07-21 | Bloch Stephen M | Director | Open-market sale | 74,444 | $79.98 | $5.95M | Form 4 |
| 2026-07-20 | Bloch Stephen M | Director | Open-market sale | 3,596 | $79.55 | $286.1K | Form 4 |
| 2026-07-13 | Boyle Dana | Officer (Chief Accounting Officer) | Open-market sale | 8,361 | $71.52 | $598.0K | Form 4 |
| 2026-07-13 | Boyle Dana | Officer (Chief Accounting Officer) | Open-market sale | 641 | $71.39 | $45.8K | Form 4 |
| 2026-07-13 | Moomaw Scott | Officer (Chief Commercial Officer) | Open-market sale | 8,864 | $71.52 | $634.0K | Form 4 |
| 2026-07-13 | Moomaw Scott | Officer (Chief Commercial Officer) | Open-market sale | 675 | $71.39 | $48.2K | Form 4 |
| 2026-07-13 | Saggar Rajeev | Officer (Chief Medical Officer) | Open-market sale | 9,223 | $71.52 | $659.6K | Form 4 |
| 2026-07-13 | Saggar Rajeev | Officer (Chief Medical Officer) | Open-market sale | 703 | $71.39 | $50.2K | Form 4 |
| 2026-07-13 | Schundler Russell | Officer (General Counsel) | Open-market sale | 13,692 | $71.52 | $979.3K | Form 4 |
| 2026-07-13 | Schundler Russell | Officer (General Counsel) | Open-market sale | 1,046 | $71.39 | $74.7K | Form 4 |
| 2026-07-13 | Adair Jason | Officer (Chief Business Officer) | Open-market sale | 7,301 | $71.52 | $522.2K | Form 4 |
| 2026-07-13 | Adair Jason | Officer (Chief Business Officer) | Open-market sale | 562 | $71.39 | $40.1K | Form 4 |
| 2026-07-13 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Open-market sale | 32,744 | $71.52 | $2.34M | Form 4 |
| 2026-07-13 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Open-market sale | 2,505 | $71.39 | $178.8K | Form 4 |
| 2026-07-13 | Kaseta Michael | Officer (CFO and COO) | Open-market sale | 18,977 | $71.52 | $1.36M | Form 4 |
| 2026-07-13 | Kaseta Michael | Officer (CFO and COO) | Open-market sale | 1,453 | $71.39 | $103.7K | Form 4 |
| 2026-07-13 | Khindri Sanjeev | Officer (Chief Development Officer) | Open-market sale | 1,101 | $71.52 | $78.7K | Form 4 |
| 2026-07-13 | Khindri Sanjeev | Officer (Chief Development Officer) | Open-market sale | 84 | $71.39 | $6.0K | Form 4 |
| 2026-07-13 | Krepp Sarah | Officer (Chief Human Resource Officer) | Open-market sale | 7,306 | $71.52 | $522.5K | Form 4 |
| 2026-07-13 | Krepp Sarah | Officer (Chief Human Resource Officer) | Open-market sale | 558 | $71.39 | $39.8K | Form 4 |
| 2026-07-10 | Boyle Dana | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 3,179 | — | $0 | Form 4 |
| 2026-07-10 | Boyle Dana | Officer (Chief Accounting Officer) | Option exercise / conversion | 3,179 | — | — | Form 4 |
| 2026-07-10 | Moomaw Scott | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 4,358 | — | $0 | Form 4 |
| 2026-07-10 | Moomaw Scott | Officer (Chief Commercial Officer) | Option exercise / conversion (derivative) | 3,108 | — | $0 | Form 4 |
| 2026-07-10 | Moomaw Scott | Officer (Chief Commercial Officer) | Option exercise / conversion | 4,358 | — | — | Form 4 |
| 2026-07-10 | Moomaw Scott | Officer (Chief Commercial Officer) | Option exercise / conversion | 3,108 | — | — | Form 4 |
| 2026-07-10 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 4,487 | — | $0 | Form 4 |
| 2026-07-10 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 3,531 | — | $0 | Form 4 |
| 2026-07-10 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion | 4,487 | — | — | Form 4 |
| 2026-07-10 | Saggar Rajeev | Officer (Chief Medical Officer) | Option exercise / conversion | 3,531 | — | — | Form 4 |
| 2026-07-10 | Schundler Russell | Officer (General Counsel) | Option exercise / conversion (derivative) | 6,409 | — | $0 | Form 4 |
| 2026-07-10 | Schundler Russell | Officer (General Counsel) | Option exercise / conversion (derivative) | 3,759 | — | $0 | Form 4 |
| 2026-07-10 | Schundler Russell | Officer (General Counsel) | Option exercise / conversion | 6,409 | — | — | Form 4 |
| 2026-07-10 | Schundler Russell | Officer (General Counsel) | Option exercise / conversion | 3,759 | — | — | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 3,869 | — | $0 | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 2,475 | — | $0 | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion (derivative) | 3,907 | — | $0 | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 3,869 | — | — | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 2,475 | — | — | Form 4 |
| 2026-07-10 | Adair Jason | Officer (Chief Business Officer) | Option exercise / conversion | 3,907 | — | — | Form 4 |
| 2026-07-10 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 14,333 | — | $0 | Form 4 |
| 2026-07-10 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 13,834 | — | $0 | Form 4 |
| 2026-07-10 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 14,333 | — | — | Form 4 |
| 2026-07-10 | JEFFS ROGER | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 13,834 | — | — | Form 4 |
| 2026-07-10 | Kaseta Michael | Officer (CFO and COO) | Option exercise / conversion (derivative) | 7,050 | — | $0 | Form 4 |
| 2026-07-10 | Kaseta Michael | Officer (CFO and COO) | Option exercise / conversion (derivative) | 5,829 | — | $0 | Form 4 |
| 2026-07-10 | Kaseta Michael | Officer (CFO and COO) | Option exercise / conversion | 7,050 | — | — | Form 4 |
| 2026-07-10 | Kaseta Michael | Officer (CFO and COO) | Option exercise / conversion | 5,829 | — | — | Form 4 |
| 2026-07-10 | Krepp Sarah | Officer (Chief Human Resource Officer) | Option exercise / conversion (derivative) | 3,179 | — | $0 | Form 4 |
| 2026-07-10 | Krepp Sarah | Officer (Chief Human Resource Officer) | Option exercise / conversion | 3,179 | — | — | Form 4 |
| 2026-07-07 | Bloch Stephen M | Director | Open-market sale | 27,282 | $81.31 | $2.22M | Form 4 |
| 2026-07-07 | Bloch Stephen M | Director | Open-market sale | 22,718 | $80.48 | $1.83M | Form 4 |
| 2026-07-06 | Bloch Stephen M | Director | Open-market sale | 25,000 | $80.18 | $2.00M | Form 4 |
| 2026-07-01 | Bloch Stephen M | Director | Open-market sale | 853 | $80.05 | $68.3K | Form 4 |
| 2026-07-01 | Bloch Stephen M | Director | Open-market sale | 24,147 | $79.45 | $1.92M | Form 4 |
| 2026-06-22 | Bloch Stephen M | Director | Open-market sale | 30,500 | $76.18 | $2.32M | Form 4 |
| 2026-06-22 | Bloch Stephen M | Director | Open-market sale | 69,500 | $75.54 | $5.25M | Form 4 |
| 2026-06-16 | Manning Paul B | Director | Grant / award / vesting | 5,882 | — | $0 | Form 4 |
Ask the chat about LQDA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: LIQUIDIA CORP (LQDA).
Last updated 2026-10-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.